Skip to content
Research Article Open access CC BY 4.0

Cannabidiol, the Journey of Cannabis from a Social Stigma to a Miracle Drug in Dentistry

Abeer Mishra, Shweta Sedani, Pradnya Nikhade, Aditya Patel, Nidhi Adyalkar, Utkarsh Umre

European Journal of Medicinal Plants · pp. 28–32 · Published 7 Oct 2022

10.9734/ejmp/2022/v33i1030494

Abstract

In recent years, there has been a surge in the awareness regarding the phyto cannabinoid; cannabidiol. Between the time period from 1963 to 2000, only 460 publications can be found in a PubMed search while using cannabidiol as the keyword. The former pales in comparison to the record of 2769 publications found from 2008 to the present time. However, a limited amount of literature is available that discusses the therapeutic potential of cannabidiol, pertaining to the field of dentistry. In 1940, cannabidiol was isolated from cannabis for the first time, its structure being reported much later in 1963. Further research on Cannabis resulted in the declaration that “THC” is the active compound. Subsequent studies were then directed essentially based on the virtual exclusion of cannabidiol and other cannabinoids from cannabis. This was primarily due to the belief that the activity of cannabis was merely psychological activity. In retrospect, this seems unfortunate as many of the beneficial properties of cannabidiol which might have had a therapeutic benefit were overlooked. In the present review, attention will be focused on the therapeutic potential of Cannabidiol and the impact this may have on dentistry with the supplemental vision of encouraging further studies to reveal any other beneficial properties that may be present.

Cannabinoid dentistry analgesia antibacterial osteogenesis myorelaxant

References (13)

  1. 1 Effects of ipsapirone and cannabidiol on human experimental anxiety [DOI]
  2. 2 Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow [DOI]
  3. 3 Cannabinoids in the management of difficult to treat pain [DOI]
  4. 4 Pharmacological actions and therapeutic uses of cannabis and cannabinoids [DOI]
  5. 5 Early medical use of cannabis [DOI]
  6. 6 Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain [DOI]
  7. 7 Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial [DOI]
  8. 8 Analgesic and antiinflammatory activity of constituents ofCannabis sativa L. [DOI]
  9. 9 Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice [DOI]
  10. 10 Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [DOI]
  11. 11 Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports [DOI]
  12. 12 Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells [DOI]
  13. 13 CANNABIDIOL HAS THERAPEUTIC POTENTIAL FOR MYOFASCIAL PAIN IN FEMALE AND MALE PARKINSONIAN RATS [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

35

Page views

0

PDF downloads

16

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.